Fig. 6From: Diagnostic potential of a circulating miRNA model associated with therapeutic effect in heart failureCorrelation analysis of the miRNA signature with HF classification and subtypes. A, B Expression levels of circulating miR-30a-5p (A) and miR-654-5p (B) in the 40 controls (Ctrl), 25 patients with NYHA class I and II and 55 patients with NYHA class III and IV. C, D Expression levels of circulating miR-30a-5p (C) and miR-654-5p (D) in the 40 controls (Ctrl), 21 patients with Ischemic cardiomyopathy (ICM), 42 patients with dilated cardiomyopathy (DCM) and 17 patients with other cardiovascular diseases. p < 0.05 was considered as statistically significance. ns means non significantBack to article page